BDBM492884 N-((5-chloro-1H- indazol-3-yl)methyl)-3- (1-(4-((2-oxopyridin- 1(2H)- yl)methyl)phenyl)vinyl) benzamide::US10981893, Example 13

SMILES C=C(c1ccc(Cn2ccccc2=O)cc1)c1cncc(C(=O)NCc2n[nH]c3ccc(Cl)cc23)c1

InChI Key InChIKey=NOZOSROFZDYHIK-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 492884   

TargetPlasma kallikrein(Human)
Attune Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 492884BDBM492884(US10981893, Example 13 | N-((5-chloro-1H- indazol-...)
Affinity DataIC50: 5.50E+3nMAssay Description:The ability of the compounds disclosed herein to inhibit human plasma kallikrein activity was quantified according to the procedures below.A 10 mM so...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/26/2021
Entry Details
US Patent